Enhancing Drug Bioavailability & Solubility
With only 1 Week to go, do not miss your opportunity to attend the industry's leading drug formulation conference.
Learn from the industry's most accomplished drug formulation and preformulation experts. Join 90+ executives from 50+ leading organizations to discuss and hear unique take-home examples, case studies and multiple formulation and preformulation strategies to assist in improving drug solubility and bioavailability, maximizing exposure, and reducing time-to-market on future drug products.
What Will You Learn?
- Pharmaceutical formulation development strategies for successful product development
- Maximizing exposure for new compounds in early formulation development
- Product diversification and enhancement through pre-formulation technologies
- Solution behavior of amorphous solid dispersions and their bioavailability implications
- Examining if cocrystal solubility in biorelevant media can be predicted
- Expedited formulation development guided by biopharmaceutical modeling
- Characterization, design and development of super saturation based drug delivery
- Solubilization approaches for parenteral routes of administration
Benefit from industry participation from Pfizer, Merck, Novartis, Bristol-Myers Squibb, GlaxoSmithKline, Amgen, Roche, Lexicon Pharmaceuticals, Vertex Pharmaceuticals, Allergan, AstraZeneca, AustarPharma, and many more formulation and drug development innovators. Additionally, hear from Keynote, Professor Stephen Byrn (Purdue University) regarding Expediting Time-to-Market and Reducing Time-to-Launch with Physicochemical Optimization as well as Professor’s Naír Rodríguez-Hornedo (U. Michigan) and Mike Zaworotko (S.Florida) regarding cocrystal enhancement strategies.
Do not miss the workshop sessions:
(A) Assessing technologies for efficient development of amorphous solid dispersions
(B) Utilizing strategies for solid form screening, characterization and selection
(C) Understanding how improving solubility can enhance your IP position
Participating organizations include:
Abbott Labs Bristol-Myers Squibb | MedImmune Merck & Co. Millennium Pharmaceuticals Netzsch Premier Technologies, LLC. Northeastern University Novartis Pharmaceuticals Patheon Inc. Pion, Inc. Pfizer, Inc. PharmaForm Pharmatek Laboratories Pharmavite, LLC Purdue University Seventh Street Development Group Sanofi Sirius Analytical Takeda Pharmaceuticals North America Tillotts Pharma AG TransTech Pharma University of Kentucky University of Michigan University of South Florida Vertex Pharmaceuticals Xcelience, LLC |
Who Should Attend
This conference is specifically designed for pharmaceutical, biotech and academic professionals specializing in:
- Formulation
- Pre-Formulation
- Medicinal / Analytical / Solid state Chemistry
- Preclinical / Analytical Development
- Drug Delivery
- Drug Discovery
- Life-Cycle / Portfolio Management
- Partnering, Licensing & Alliance Management
- Intellectual Property
- Product Enhancement / Development
- Toxicology
- Pharmaceutics
- Physiochemistry
- Chemical Engineering
- Process R&D
Chat With Us
*Live Chat is available
9:00AM - 5:00PM EST.
Expediting Time-to-Market and Reducing Time-to-Launch with Physicochemical Optimization
- Achieving the right balance between efficacy, patentability concerns, toxicity, and ADME properties for your compound
- Examining key strategies for managing solubility in lead optimization
- Effectively selecting the correct form and correct salt of your drug substance
- Evaluating physicochemical properties, generating an understanding of the material's stability under various conditions, leading to selecting the optimal drug delivery system
Stephen R. Byrn, PhD, Charles B. Jordan Professor of Medicinal Chemistry, Purdue University
Sponsors
